Company Profiles

driven by the PitchBook Platform

NantCell

NantCell
2014 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$9.2M LATEST DEAL AMOUNT
Description

Developer of molecular-level cell-based treatments. The company develops immunology based treatments and drugs for the treatment of cancer and auto-immune diseases.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
9920 Jeffersoon Boulvard
Culver City, CA 90232
United States

+1 (310) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NantCell’s full profile, request a free trial.

NantCell Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 14-Apr-2017 $9.2M 00000 Completed Startup
1. Undetermined 21-Jan-2016 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NantCell Investments & Acquisitions (4)

Company Name Date Type Deal Size Industry Lead Partner
00000 0000000000 01-Aug-2017 000000000000000000 00.000 Biotechnology 0000000 0000-000000
00000000000 23-Mar-2017 000000000000000000 00.00 Biotechnology 0000000 0000-000000
0000000 01-Jan-2016 000000000000000000 Other Devices and Supplies
Etubics 01-Oct-2015 Later Stage VC 0000 Other Devices and Supplies
To view this company’s complete investment and acquisition history, request access »

NantCell Executive Team (1)

Name Title Board
Seat
Contact
Info
Patrick Soon-Shiong Founder & Chief Executive Officer
Questions or concerns about this profile? Reach out to website-support@pitchbook.com